Advisor Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$4.81M Buy
9,965
+321
+3% +$155K 0.34% 55
2022
Q1
$4.74M Buy
9,644
+661
+7% +$325K 0.3% 61
2021
Q4
$4.16M Buy
8,983
+286
+3% +$133K 0.25% 72
2021
Q3
$3.24M Sell
8,697
-176
-2% -$65.6K 0.22% 86
2021
Q2
$3.39M Sell
8,873
-39
-0.4% -$14.9K 0.22% 83
2021
Q1
$3.2M Sell
8,912
-683
-7% -$245K 0.23% 81
2020
Q4
$3.08M Buy
9,595
+294
+3% +$94.4K 0.23% 80
2020
Q3
$2.5M Sell
9,301
-122
-1% -$32.8K 0.21% 85
2020
Q2
$2.48M Buy
9,423
+712
+8% +$187K 0.23% 83
2020
Q1
$1.98M Buy
8,711
+361
+4% +$81.9K 0.24% 89
2019
Q4
$2.52M Buy
8,350
+156
+2% +$47K 0.26% 78
2019
Q3
$1.97M Buy
8,194
+186
+2% +$44.7K 0.24% 81
2019
Q2
$2.26M Sell
8,008
-365
-4% -$103K 0.28% 71
2019
Q1
$2.4M Sell
8,373
-246
-3% -$70.6K 0.31% 65
2018
Q4
$2.26M Buy
8,619
+972
+13% +$255K 0.36% 60
2018
Q3
$2.1M Buy
7,647
+38
+0.5% +$10.4K 0.28% 69
2018
Q2
$1.81M Buy
7,609
+247
+3% +$58.8K 0.31% 68
2018
Q1
$1.62M Buy
7,362
+31
+0.4% +$6.81K 0.3% 71
2017
Q4
$1.83M Buy
7,331
+144
+2% +$36K 0.33% 64
2017
Q3
$1.37M Sell
7,187
-145
-2% -$27.5K 0.27% 77
2017
Q2
$1.38M Buy
7,332
+198
+3% +$37.2K 0.32% 73
2017
Q1
$1.18M Buy
7,134
+1,072
+18% +$177K 0.31% 76
2016
Q4
$872K Buy
6,062
+685
+13% +$98.5K 0.26% 97
2016
Q3
$674K Sell
5,377
-737
-12% -$92.4K 0.22% 113
2016
Q2
$803K Buy
6,114
+189
+3% +$24.8K 0.28% 94
2016
Q1
$824K Sell
5,925
-908
-13% -$126K 0.31% 92
2015
Q4
$953K Buy
6,833
+89
+1% +$12.4K 0.33% 89
2015
Q3
$944K Sell
6,744
-409
-6% -$57.3K 0.4% 71
2015
Q2
$1.12M Buy
7,153
+554
+8% +$87.1K 0.43% 68
2015
Q1
$1.02M Buy
6,599
+1,200
+22% +$185K 0.43% 63
2014
Q4
$678K Buy
+5,399
New +$678K 0.3% 103
2014
Q3
Sell
-6,773
Closed -$729K 247
2014
Q2
$729K Buy
6,773
+335
+5% +$36.1K 0.36% 87
2014
Q1
$641K Buy
6,438
+144
+2% +$14.3K 0.35% 87
2013
Q4
$581K Buy
6,294
+214
+4% +$19.8K 0.33% 94
2013
Q3
$508K Buy
6,080
+218
+4% +$18.2K 0.36% 92
2013
Q2
$480K Buy
+5,862
New +$480K 0.39% 88